Evidence map›Paper›PMID 39448456›Full record

ArticleCellular and molecular life sciences : CMLS2024

Human TRPV1 is an efficient thermogenetic actuator for chronic neuromodulation.

Dmitry I Maltsev, Maxim A Solotenkov, Liana F Mukhametshina, Rostislav A Sokolov, Georgy M Solius, David Jappy, Aleksandra S Tsopina, Ilya V Fedotov, Aleksandr A Lanin, Andrei B Fedotov and 7 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dmitry I Maltsev *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia.
Maxim A Solotenkov *Lomonosov Moscow State University, 119991, Moscow, Russia.
Liana F Mukhametshina *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia.
Rostislav A SokolovPirogov Russian National Research Medical University, 117997, Moscow, Russia.
Georgy M SoliusShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia.
David JappyFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117997, Moscow, Russia.
Aleksandra S TsopinaLomonosov Moscow State University, 119991, Moscow, Russia.
Ilya V FedotovLomonosov Moscow State University, 119991, Moscow, Russia.
Aleksandr A LaninLomonosov Moscow State University, 119991, Moscow, Russia.
Andrei B FedotovLomonosov Moscow State University, 119991, Moscow, Russia.
Viktoriya G Krut'Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117997, Moscow, Russia.
Yulia G ErmakovaEuropean Molecular Biology Laboratory (EMBL), 69117, Heidelberg, Germany.
Aleksandr A MoshchenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117997, Moscow, Russia.
Andrei RozovFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117997, Moscow, Russia. rozov1511@gmail.com.
Aleksei M ZheltikovLomonosov Moscow State University, 119991, Moscow, Russia. zheltikov@physics.msu.ru.
Oleg V PodgornyShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia. olegpodgorny@inbox.ru.ORCID http://orcid.org/0000-0001-5001-250X
Vsevolod V BelousovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997, Moscow, Russia. belousov@fccps.ru.

Funding

Center for Precision Genome Editing and Genetic Technologies for Biomedicine 075-15-2019-1789Russian Science Foundation 22-22-00590Russian Science Foundation 23-15-00295Russian Science Foundation 23-75-30023
6 · The paper itself

Abstract

Thermogenetics is a promising neuromodulation technique based on the use of heat-sensitive ion channels. However, on the way to its clinical application, a number of questions have to be addressed. First, to avoid immune response in future human applications, human ion channels should be studied as thermogenetic actuators. Second, heating levels necessary to activate these channels in vivo in brain tissue should be studied and cytotoxicity of these temperatures addressed. Third, the possibility and safety of chronic neuromodulation has to be demonstrated. In this study, we present a comprehensive framework for thermogenetic neuromodulation in vivo using the thermosensitive human ion channel hTRPV1. By targeting hTRPV1 expression to excitatory neurons of the mouse brain and activating them within a non-harmful temperature range with a fiber-coupled infrared laser, we not only induced neuronal firing and stimulated locomotion in mice, but also demonstrated that thermogenetics can be employed for repeated neuromodulation without causing evident brain tissue injury. Our results lay the foundation for the use of thermogenetic neuromodulation in brain research and therapy of neuropathologies.

Indexed as

BrainNeuronsTRPV Cation ChannelsAnimalsHumansLocomotionMaleMiceMice, Inbred C57BLTRPV1 protein, humanTRPV Cation ChannelsCalcium imagingNeuromodulationNeuronal activityThermogeneticsTRP channelsTRPV1

Identifiers

PMID39448456
PMCPMC11502623

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.